
View larger version (110K):
[in this window]
[in a new window]
|
Fig. 6. Depletion of E-cadherin in the ventral (non-neural) ectoderm causes
reduction of F-actin. (A,B) Injection of E-cadherin MO into
single ventral animal cells (arrow in A) gives rise to large clones of cells
depleted of E-cadherin protein (lower panel in A, B). Arrows in B indicate
boundaries between injected cells (*) and uninjected cells (#),
which express E-cadherin. (C) Reduction of F-actin in
E-cadherin-depleted cells (*) as compared with uninjected cells
(#). (D,E) Reduction, but not absence, of F-actin in
E-cadherin-depleted cells (D, lower panel), probably because of continued
expression of C-cadherin, as shown en face and in cross-section in E.
(F) Most of the non-neural ectoderm is labeled by injection of both
ventral animal cells at the 8-cell stage. The same embryo is shown in the
center and lower panels during neural fold closure, which is delayed compared
with untreated embryo (left) owing to reduced pushing movements of the
non-neural ectoderm (NE). (G) Rescue of the cortical actin skeleton by
injection of an MO-resistant form of E-cadherin mRNA into the cell injected
with E-cadherin MO. The asterisk marks the treated cells; #, adjacent
untreated cells. Four images are shown of the same field of view. The RLDX
(blue) and anti-HA (red) staining show the expression of the HA-tagged mRNA in
the same cells as those injected with the MO (co-injected with RLDX), whereas
the Phalloidin staining (green) shows increased assembly of F-actin in the
injected cells (compare with C, where actin staining is reduced in the
MO-injected cells). Scale bars: 100 µm in B,C,G; 20 µm in D,E.
|